Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02963493
Title A Study of Melflufen in Combination With Dexamethasone in Relapsed Refractory Multiple Myeloma Patients (HORIZON)
Acronym HORIZON
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oncopeptides AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP


No variant requirements are available.